E. Anders Kolb, M.D. is pediatric hematologist oncologist and researcher, and he current president and chief executive officer of The Leukemia & Lymphoma Society (LLS).  Before joining LLS, he spent 15 years at Nemours Children's Health, where he built the Blood and Bone Marrow Transplant Program and most recently served as chief of the Division of Hematology and Oncology, Director of the Moseley Foundation Institute for Cancer and Blood Disorders, and Vice Chairman for Research in the Department of Pediatrics at the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Kolb has been the principal or co-principal investigator of numerous studies and grants, including clinical trials with the Children's Oncology Group, the Nemours NCI Community Oncology Research Program (NCORP) and the Delaware Comprehensive Sickle Cell Research Center. From 2013 to 2023. He served as the Chair of the Children's Oncology Group Myeloid Disease Committee. From 2018 to 2023 he was co-chair and member of the executive committee of LLS PedAL. Dr. Kolb has authored or co-authored more than 150 articles in peer-reviewed journals and received numerous awards.

Dr. Kolb completed his pediatric residency at St. Christopher's Hospital for Children and completed fellowship training in hematology/oncology in the Department of Pediatrics at Memorial Sloan-Kettering Cancer Center. He earned his M.D. from Thomas Jefferson University and his bachelor's degree from the University of Pennsylvania.